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GENERAL INTRODUCTION 
The phenomenon of microbial persistence was first discovered in the 1940's by 
Bigger when he observed that penicillin was ineffective in sterilizing growing cultures of 
bacteria (6). The cells that survived antibiotic exposure were termed "persistent." Persistent 
bacteria are defined as a phenotypically distinct subpopulation of cells that can survive a 
variety of antimicrobial challenges. Subsequent studies revealed that when a growing 
bacterial population is exposed to lethal antimicrobial challenges, such as antibiotics, there is 
an observable biphasic killing response (14). While the majority of the population is killed, a 
very small subpopulation of "persisters" remain viable through the antimicrobial challenge. 
The surviving fraction of persistent cells does not grow in the presence of the antimicrobial, 
nor do they lose viability as a result of the exposure. Once the antimicrobial challenge is 
removed, the surviving persistent cells resume growth, forming new populations that remain 
just as sensitive to the antimicrobial agent. Persistent cells are genotypically identical to all 
other cells in their population but survive by being phenotypically distinct. Recently, the 
study of persisters has gained new interest since persistent cells may contribute to increased 
antibiotic resistance of biofilms. 
Since Bigger first discovered persistence, new information on the phenomena has 
been gained slowly. Mainly because persistent cells make up such a minor portion of a 
growing population. For example, persistent cells make up only 10-5 of a growing culture of 
E. coli (52). Most of the information pertaining to persistence has come from the isolation 
and characterization of high persistence mutants in E. coli. hipA (high persistence) mutants 
have significant increases in the number of persistent cells in a population. To date, 
however, hipA is the only well characterized high persistence allele known. The discovery 
on new high persistence genes would greatly advance persistence knowledge. 
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Salmonella has been recognized as the major cause of intestinal disease in humans for 
many years, but despite this knowledge it still continues to be one of the most common food-
born illnesses on the planet. Currently in the US, 30,000-40,000 cases of non-typhoidal 
salmonellosis are reported to the CDC annually, along with approximately 500 fatalities (51). 
Salmonella is an ideal test organism both for its role in human disease and the absence of 
hipA in its genome. 
Objective of the study 
The goal of this research was to isolate and characterize high persistent mutants of 
Salmonella enterica serotype Typhimurium LT2. 
Thesis Organization 
This thesis contains a manuscript which will be submitted to the Journal of 
Bacteriology. The master's candidate, Andrew Slattery, is the senior author of the paper. 
The manuscript is preceded by a literature review and followed by a general summary. 
References and acknowledgments appear after the general summary. 
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LITERATURE REVIEW 
Bacterial Persistence 
The phenomenon of microbial persistence was first discovered in the 1940's by 
Bigger when he observed that penicillin was ineffective in sterilizing growing cultures of 
bacteria (6). The cells that survived antibiotic exposure were termed "persistent." Persistent 
bacteria are defined as a phenotypically distinct subpopulation of cells that can survive a 
variety of antimicrobial challenges. Subsequent studies revealed that when a growing 
bacterial population is exposed to strong antimicrobial challenges, such as antibiotics, there is 
an observable biphasic killing response (12, 14). While the majority of the population is 
killed, a very small subpopulation of "persisters" remain viable through the antimicrobial 
challenge. The surviving fraction of persistent cells does not grow in the presence of the 
antimicrobial, nor do they lose viability as a result of the exposure. Once the antimicrobial 
challenge is removed, the surviving persistent cells resume growth, forming new populations 
that remain just as sensitive to the antimicrobial agent. In addition to antibiotics, persistent 
cells are able to survive multiple inimical stresses including starvation, metal oxyanions, 
freezing temperatures, elevated temperatures, and irradiation (23, 33, 48, 56). 
As implied, persistence is distinct from resistance and tolerance. Cells that are 
resistant not only can survive a specific antibiotic exposure, but can also grow in its presence. 
A tolerant population can not grow in the presence of the particular antibiotic, but, unlike 
persistence, all or most of the population is able to survive. In the literature, persistence is 
occasionally referred to as tolerance, as in multi-drug tolerance (32, 40, 79). However, the 
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tolerance associated with persistent cells is only temporary and not an adaptation to any 
specific antimicrobial challenge. Like persistence, resistance and tolerance are survival 
strategies, but the latter are, in general, specific to the antimicrobial to which they are 
exposed. Consequently, resistance and tolerance can be overcome by merely exposing the 
bacteria to a different antimicrobial. For example, if a bacterial population becomes resistant 
or tolerant to a cell wall synthesis inhibiting antibiotic, killing can be achieved by 
administering an antibiotic that targets a different physiological process. Persistence, 
however, is a general phenomenon that allows microbial populations to survive a variety of 
antimicrobial agents, making the use of alternative antimicrobials ineffective. Another 
advantage of persistence is that it allows a species to survive antimicrobial challenges that are 
extremely difficult to adapt to by mutation. For example, persistent cells show no higher 
sensitivity to multiple antimicrobial challenges administered in combination or in series, than 
when exposed to a single antibiotic (20). 
Research indicates that most, if not all, bacteria display the persistence phenotype. 
Despite its common occurrence, persistence remains an enigmatic cellular process. The lack 
of understanding of the genetic basis for persistence is in part a result of the almost exclusive 
study of bacterial growth in balanced growth phase. The occurrence of persistent cells is 
usually ignored mainly due to the fact that in all stages of growth other than stationary phase 
they make up such a small proportion of a population. Consequently, the contribution that 
persistent cells make to the overall physiological state of a bacterial population is negligible. 
Researchers also tend to overlook their potential significance in antimicrobial resistance. 
When dealing with antibiotics, most researchers are usually more concerned with how many 
cells in a population are killed by an agent, not a small fraction that survive. The minimum 
bacteriocidal concentration (MBC), which is the minimal concentration of an antibiotic that 
can kill 99.99% of a cell population is a key measurement of bacterial survival. However, 
the reason that 100% is not the standard in an MBC concentration assay is due to the 
presence of persistent cells, which prevent complete killing of a bacterial population. 
Characterization of persistent cells 
One of the first observations about persistence after its discovery was the heritability 
of the phenotype (6). After treatment of a bacterial culture with an antibiotic a viable 
subpopulation results. Upon removal of the antibiotic the persistent cells resume growth. 
When this population is exposed to the same antibiotic, a new persistent subpopulation is 
formed at the same ratio as the original population (6, 68). This is reproducible and 
continuous growth/killing assays have shown no increase in persistence ratios. An 
experiment showing the heritability of persistence done by Keren et al. is shown in Figure 1 
(39). These results are reproducible as long as no spontaneous resistant mutants appear 
during the repeated growth/exposure cycles. This is not a consideration for the experiments 
depicted in Figure 1, however, since it is very difficult for Escherichia coli to spontaneously 
mutate to become resistant to high concentrations of ampicillin without horizontal gene 
transfer from a resistant strain. These results underscore that while the population is 
genetically homogenous, they are phenotypically heterogeneous. 
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Figure 1 Heritability of Persistence. An overnight culture of E. coli was diluted and grown to mid-exponential phase (108 
CFU/ml). Once exponential phase was reached, the culture was exposed to 100 µg/ml of ampicillin for three hours. After 
antibiotic exposure cells were washed and regrown overnight. The same growth/antibiotic exposure regimen was repeated 
four times sequentially (39). 
Further experiments found that increasing the concentration of antibiotics produce 
increased killing only up to a certain point (14, 78). At this plateau a saturation point for 
antibiotic activity is reached (Figure 2). Increasing the antibiotic concentrations beyond this 
plateau results in little or no increase in killing. Thus, higher concentrations, as well as 
combinations of antibiotics, are incapable of sterilizing a bacterial culture. 
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Figure 2 Killing of Pseudomonas aeruginosa cells by carbenicllin. Cells of logarithmic-phase, stationary-
phase, and biofilm cultures were treaded with carbenicllin for 6 hours and plated for colony counting (66). 
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In addition to being able to survive high concentrations of antibiotics, persistent cells 
have the ability to survive exposures for extended periods of time. For example, it was 
observed that persistent E. coli survive exposures to high concentrations of ampicillin for up 
to 30 days, during which there is a slow gradual decline in the persistent subpopulation (17). 
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It is well established that slower rates of growth correlate with higher levels of 
persistence (24, 28). This is observed especially well with antibiotics such as peptidoglycan 
synthesis inhibitors, which specifically target actively growing cells (70). Bacterial 
populations in biofilms and in stationary phase both have very high levels of persistent cells 
(66), and are also associated with slow growth (Figure 2) (26). It is now thought that 
persistent cells are in fact in a nongrowing or slow growing state prior to being exposed to an 
antimicrobial agent (3, 39). This conclusion is based on the observations that the quantity of 
persistent cells in lag and early log phase do not change and are inoculum dependant (3, 39), 
and by direct observations and recordings using microfluidic devices (3). In this latter study 
using high persistent mutants of E. coli, it was shown that persistent cells could be observed 
by their slowed or inhibited growth prior to antibiotic exposure. This evidence is consistent 
with other studies that have shown that slower growing populations have higher proportions 
of persistent cells. 
Growth phase effect on persistence 
The ratio of persistent cells to nonpersistent cells in a population varies with changing 
growth phases (39). Figure 3 shows the effect of growth phase on the proportion of 
persistent cells in E. coli challenged with either ampicillin or ofloxacin. Ampicillin is a ~-
lactam antibiotic that inhibits peptidoglycan synthesis and kills only actively dividing 
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bacteria. Ofloxacin is a fluoroquinolone that targets DNA gyrase and is active against both 
growing and nongrowing bacteria (24). In the first few stages of active growth, consisting of 
lag phase to mid-exponential phase, the number of persistent cells does not change, although 
the total cell number is increasing. This suggests that no new persistent cells are being 
created during this period, and the persisters that are observed are cells carried over from 
stationary phase. A study done by the Keren et al. found that the number of persistent cells 
could be reduced by maintaining a bacterial population in early exponential phase maintained 
by continual dilution into fresh medium (39). Additional evidence for this conclusion is that 
higher volume inoculations of stationary phase bacteria correlate with higher numbers of 
persistent cells in lag and early 
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Figure 3 Growth-stage dependence of persistence. A culture of E. coli was grown at 37°C for 10 hours. 
Samples were removed at various times and exposed to ampicillin and ofloxacin. Samples were exposed to 
antibiotics for 3 hours, plated on LB plates, and grown overnight to assay persister numbers. ( 17) 
exponential phase (3, 39). It is important to note that in the experiment shown in Figure 3 the 
number of persistent cells that are carried over from stationary phase is the same for 
ampicillin and ofloxacin exposed populations. Since ofloxacin kills more than 90% of the 
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nongrowing cells in stationary phase, this means that persistent cells in lag and earlier 
exponential phase that are carried over from stationary phase are more than just nongrowing, 
they are in a physiological state that protects them from being killed. 
As the population progresses through its typical growth phases, new persistent cells 
begin to arise in mid-log phase. The development of new persistent cells rises rapidly from 
mid-exponential phase and peaks in stationary phase. Once stationary phase is reached, 
nearly all cells in the population have stopped dividing and survive ampicillin exposure (39). 
The level of ofloxacin killing plateaus as well (39). 
Persistence of wild type E. coli can be divided into two categories: I and II (3). Type 
I persisters constitute a preexisting population of nongrowing cells that are generated in 
stationary phase (3). Once inoculated into new medium, type I persistent cells have delayed 
growth and their numbers are dependent on the stationary inoculum volume. Type II 
persistent cells do not originate from stationary phase, rather are the result of spontaneous 
switching from growth to slow or nongrowth (3) that is independent of stationary phase. 
Both type I and II persistent cells preexist before the application of antibiotics. 
Persistence as an evolutionary adaptation 
Bacteria have evolved sophisticated mechanisms that have allowed them to adapt to 
heat, antimicrobial agents, cold, irradiation, oxidative damage, and nutritional deprivation. 
For example, bacteria are known to have adaptations such as sporulation (31) and elevated 
mutator phenotypes (30) that are used to cope with an ever-changing and unpredictable 
environment. Since the ratio of persistent to nonpersistent cells within a bacterial populatin 
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is reproducible, it must somehow be genetically determined, and thus appears to be another 
evolutionary adaptation used to cope with suddenly changing environments. By genetically 
establishing the proportion of cells able to enter into a persistent state, bacteria are most 
likely at their maximum fitness levels, balancing the advantages of having a subpopulation of 
highly durable reserves and the disadvantages of having a portion of the population that is 
not actively proliferating. Even in the most favorable of environments, persistent cells give a 
vulnerable population of growing bacteria an "insurance policy" by at all times maintaining a 
portion of the population survive sudden environmental challenges. Persistence could also 
contribute to heritable change in a population, such as antibiotic resistance, by allowing more 
chance for mutation or horizontal gene transfer to occur. 
Possible explanations of persistence 
Various explanations for the physiological basis for persistence have been proposed. 
For example, it has been proposed that a portion of a bacterial population are in a 
nongrowing state as a result of a disruption in the cell cycle resulting from an anti-stress 
response (6). One stress response system known to trigger a block in the cell cycle is the 
SOS DNA repair system (20). As part of the SOS DNA repair response cell division is 
blocked by the activity of the SOS inducible gene sulA. The rationale behind this event is 
that a temporary halt of cell division allows the cell to undergo DNA repair prior to cell 
division (20). This persistence hypothesis suggests that cells survive exposure to 
antimicrobials by fortuitously being in an arrested growth state undergoing DNA repair. In 
this scenario the cells not only survive, but may actually adapt more rapidly to the presence 
of antibiotics (20). 
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To directly test this model, Debbia et al.(20) manipulated the DNA repair response in 
various ways and then tested cultures in exponential growth for persistence to antibiotics. 
Strains with the mutant allele lexA3, which can not induce DNA repair, and wild type lexA + 
strains were exposed to the various antibiotics. It was found that lexA3 mutants showed 
reduced ability to survive every antibiotic to which they were exposed. On average, lexA + 
strains showed about 10 to 100 times higher persistent cell levels than lexA3 mutants. 
However, the lexA3 mutants still yielded some persistent cells, indicating that while the DNA 
repair response may contribute to persistence is not the sole determinant. 
Persistence was also assayed in populations were SOS repair was induced. Induction 
was done by exposing E. coli to mitomycin C prior to addition of antibiotics. It was found 
that populations in which DNA repair was induced before the addition of antibiotics had a 
higher proportion of persistent cells than uninduced cultures, showing that the SOS response 
induction can increase natural persistence. However, it is difficult to assign a direct link 
between SOS and persistence since one of the side effects of mitomycin C is slowed growth. 
As mentioned earlier, slower growing cultures have higher proportions of persistent cells, 
making it difficult to assign a direct role of DNA repair in persistence. 
Although DNA repair mechanisms may be involved in formation of persistent cells, it 
does not appear that all persisters are undergoing DNA repair. An interesting possibility 
might be that persistent cells use some of the same mechanisms and gene products to stop 
cell growth that are also turned on in DNA repair. Again, since persistent cells are still 
present in strains lacking the ability to induce SOS, DNA repair systems can not be the only 
cause of persistence. Furthermore, DNA repair does not adequately explain the increase in 
persistence in late log and stationary phase. 
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Another explanation proposed for persistence is that antibiotic induced cell death is a 
result of oxidative shock (11, 21, 68). In this hypothesis cell death is the result of an 
inhibition of a cell's anabolic or biosynthetic reactions which causes a build up of 
catabolically derived free radical substrates that ultimately destroy the cell. Persistent cells in 
this hypothesis are cells that can adjust to increased catabolic free radicals using protective 
enzymes such as catalase and superoxidedismutase. If the increased levels of 
protective/repair enzymes were the result of mutation it would be heritable, and regrowing 
the persistent cells would generate a population with complete tolerance to the antimicrobial. 
However, if the levels of protective enzyme were a result of random molecular fluctuations, 
it might explain why these cells can survive oxidative stress, but not show a heritable trait. 
Additional explanations for persistence 
Kim Lewis has proposed two additional explanations of persistence. The first 
includes antibiotic killing of bacteria as a result of programmed cell death (PCD) ( 45). 
Although most commonly associated with eukaryotic cells, PCD has been recorded in 
microbial developmental pathways including fruiting body formation and sporulation (45). 
In this hypothesis, when a bacterial population is exposed to an antimicrobial challenge the 
majority of cells in a population die as a result of the induction of PCD. Persistent cells, 
therefore, represent a small minority of the population not undergoing PCD. In this model, 
PCD of the majority of the population could further help the survival of the population by 
providing the few surviving cells available nutrients that can be utilized after the passing of 
the antimicrobial (7). 
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A second explanation for survival of persistent cells proposed by Lewis includes the 
disabling of antibiotic targets ( 44) (Figure 4 ). In this hypothesis, killing by antibiotics is 
achieved not by complete cessation of essential cell functions, but by "corrupting" them (39, 
44 ). For instance, inhibiting protein synthesis by erythromycin is bacteriostatic, where as 
corruption of protein synthesis by streptomycin is bacteriocidal. This model of persistence 
suggests that the antibiotic can still bind to its target, but it cannot produce a corrupt 
condition. By using a general mechanism that disables antibiotic corruption, persistent cells 
avoid death. Lewis further suggests that toxin-antitoxin modules are the agents that disable 
antibiotic targets. Toxin-antitoxin modules were first discovered as a unique mechanism of 
plasmid retention (27). In this system, a plasmid contains a gene that produces a stable toxin 
protein as well as a gene that produces an unstable antitoxin protein. If a newly formed cell 
does not inherit a copy of the plasmid, the antitoxin is quickly degraded leaving the more 
stable toxin to block an essential cellular process. Since their discovery in plasmid retention 
systems, toxin/antitoxin modules have been found on bacterial genomes as well, although 
their purpose in this location is not well understood. In this hypothesis of persistence, it is 
said the "toxin" part of a toxin-antitoxin module is not lethal but rather is bacteriostatic. 
Lewis proposes that the toxins ability to stall ribosomes causes antibiotic targets such as 
DNA synthesis, cell wall synthesis, and protein synthesis to cease functioning. 
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Figure 4 Toxin blocking of antibiotics. Antitoxins (A) bind to toxins (T) nullifying its function. When levels of 
toxin increase, they can shut down specific targets in a nonlethal way. These targets are then protected from 
antibiotic corruption that would otherwise be lethal (40). 
He goes on to propose that persistent cells are those that randomly have elevated levels of 
toxin that causes growth to stall resulting in survival to antibiotic exposure. Cellular growth 
is then resumed when levels of antitoxin become high enough to counter the toxin 
Research to understand persistence 
Since Bigger first discovered persistence, new information on the phenomena has 
been gained slowly. There are multiple reasons why our understanding of persistence has 
remained elusive. The foremost reason is that persistent cells make up such a small fraction 
of a bacterial population. Characterization of most bacterial processes has occurred during 
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balanced growth phase where all bacterial cells are considered identical. While this is 
important for studying physiological and biochemical processes, it ignores the heterogeneity 
inherent within a bacterial culture. For instance, when exposed to high concentrations of 
ampicillin, a growing population of E. coli in mid-exponential growth phase has a fraction of 
dormant persistent cells around 10-5 (39, 52). Given that a population in mid-exponential 
phase has 107 to 108 cells/ml, only around 102 - 103 persistent cells/ml will be present in the 
culture. To further make the analysis of this small fraction of cells even more difficult, 
persistence is only a temporary phenotypic state; cells may exit the persistent state during 
preparation for study. Moyed was the first to propose a genetic approach to isolate mutants 
displaying increased persistence is a means to study the phenomenon (52). As a result, most 
of the insight into persistence has been gained by characterization of hip (high persistence) 
mutants of E. coli. To date, only two mutants displaying a high persistence phenotype have 
been studied, hipA and hipQ. Of these two high persistence alleles, only hipA has been 
precisely mapped and well characterized (8, 9, 52, 53, 63). 
High persistence mutants of E. coli 
In 1983 Moyed used a genetic approach to understand the basis of persistence. In 
order to solve the problem of low number of persistent cells, he isolated mutants that showed 
increased levels of persistence. A screen was developed to identify mutants with increased 
persistence to a variety of cell wall inhibitors. After mutagenesis with EMS, high persistence 
mutants were enriched for by repeated exposure of cells to ampicillin. After two rounds of 
ampicillin exposure, the cells that remained were plated on LB plates with ampicillin and 
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incubated at 37° C. After 24 hours the plates were then sprayed with penicillinase and 
incubated again for 24 hours. Colonies that appeared were assayed individually for increased 
persistence to ampicillin. Mutants with the desired phenotype were then screened to 
eliminate those that showed slowed growth. The remaining mutants were then challenged 
with other antibiotics that targeted cells wall synthesis, resulting in isolation of hip (high 
persistence) mutants. Moyed later found that in addition to having increased persistence to 
cell wall inhibitors, hip also increased persistence to many other antimicrobial challenges. 
Characterization of a hip mutant revealed a mutation in a previously unknown operon 
termed hipAB. The operon is composed of two genes, hipA and hip, that code for a toxin-
antitoxin module. One of the mutants showing the high levels of persistence isolated by 
Moyed was hipA7, which results from two amino acid substitutions, G22S and D291A (42). 
To date, hipA7 is the only well characterized allele associated with high persistence and E. 
coli is the only microorganism that has yielded high persistence mutants until recently (this 
work). 
hipA 7 phenotype 
As mentioned, wall-less death was the first antimicrobial challenge to which hipA7 
mutants showed high persistence. Since its discovery, hipA7 mutants have been found to 
give high persistence to the cell wall synthesis inhibitors cycloserine, phosphomycin, 
ampicillin, and cefotaxime ( 40, 42, 52). The numbers of surviving cells in hipA7 mutants 
increased 2-3 orders of magnitude following exposure to cycloserine, 4 orders of magnitude 
with phosphomycin, 4 orders of magnitude with ampicillin, and 2 orders of magnitude with 
cefotaxime. 
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To further study the role of hipA7 persistence to cell wall synthesis inhibition, Moyed 
et al. placed hipA7 in E. coli mutants lacking the ability to synthesize diaminopimelic acid 
(DAP) (52). DAP is a component of peptidoglycan. Killing in DAP mutants was measured 
on agar plates lacking DAP, followed by addition of DAP to assay the number of surviving 
cells. In this assay it was found that the number of persistent cells increased by 4 orders of 
magnitude in strains containing hipA 7. 
Moyed et al. also investigated the role of hipA7 in cell death associated with strains 
bearing temperature-sensitive (TS) mutations in dnaA, dnaB, and dnaC (63). These 3 genes 
are essential for DNA replication. At the non-permissive temperature of 42°C, the dna 
mutants cease DNA replication, resulting in the killing of a large portion of the population. 
hipA7 mutants carrying any of these three TS mutations greatly suppressed killing by around 
3-6 orders of magnitude at the non-permissive temperature (63). 
Cell death following exposure to the DNA gyrase inhibitors nalidixic acid (63) and 
ofloxacin (40) was also reduced in hipA7 mutants. hipA7 mutants increased survival by 2 
orders of magnitude in strains exposed to ofloxacin. The exact levels of increased 
persistence of hipA7 mutants exposed to nalidixic acid were not published. 
In addition, hipA7 reduced lethality following thymine starvation in mutants lacking 
the ability to synthesize thymine (thyA). These mutants were placed on medium lacking 
thymine and killing was monitored over a 24 hour period, at which thymine was added at 
various times. Stains containing hipA7 survived much better than those containing hipA +. 
E. coli hipA7 mutants were shown to have increased numbers of persistent cells when 
challenged with protein synthesis inhibiting antibiotics as well. hipA7 mutants had around 5 
orders of magnitude more survivors than wild type when exposed to chloramphenicol, and 
around 1.5-2 orders of magnitude more survivors when exposed to tobramycin (39, 40, 63). 
There is some discrepancy as to whether hipA 7 causes higher persistence when cells were 
exposed to kanamycin ( 40, 63). 
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To further test the ability of hipA7 to protect against killing, hipA7 was transferred to 
a rpoH(htpR) mutant defective in expression of the heat shock sigma factor in E. coli (2), and 
cell viability was measured. rpoH mutants are incapable mounting a heat shock response, 
and thus a large portion die when exposed to the elevated growth temperature of 42°C. 
hipA7 and rpoH double mutants were found to survive about 3 orders of magnitude better at 
non-permissive temperatures than rpoH mutants. 
More recently it was observed that hipA7 also imparts increased persistence to metal 
oxyanion challenges (33). Unlike antibiotic challenges that target specific molecules, metal 
oxyanions cause cell death through multiple mechanisms (33). hipA7 mutants growing in 
both stationary phase and in biofilms were exposed to bactericidal concentrations of TeO~ 
and Cro!-, where it was observed that a 82-fold to 76-fold increase in survivability resulted, 
respectively (33). 
In contrast to increases in persistence governed by hipA7, improved survival was not 
observed to all antimicrobial challenges. hipA7 gave no significant increase in survival to 
UV-induced cell death in either wild type or recA mutants. 
Another phenotype of hipA7 mutants is a reversible cold sensitive block in cell 
division. At 32°C hipA7 mutants showed noticeable slowing of growth, followed by a 
cessation of cell division at 20°C. The cessation in cell division was not, however, lethal. 
Cells plated and exposed to 20°C for 24 hours before being placed back at the permissive 
temperature showed no loss in CFU as compared to plates directly placed at 37°C. It was 
also discovered that at lower temperatures peptidoglycan synthesis slowed down, closely 
paralleling that of cell division (63). 
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To ensure that the increased persistence observed in hipA7 mutants was not due to 
increased resistance, minimal inhibitory concentrations (MIC) were measured for a variety of 
antibiotics. It was found that the MIC did not increase in any of antibiotics tested, and in fact 
actually went down slightly for a few (52, 63). Although hipA7 can reduce the lethality of 
many antibiotics, it does not prevent their inhibitory effects. 
Growth phase effect on persistence of E. coli hipA7 mutants 
As observed in wild type E. coli, Keren et al. found that persistence of hipA7 mutants 
changes with the growth phase of the population (39). The effect of growth phase on 
survival of hipA7 mutants to killing by ampicillin (l00ug/ml) and ofloxacin (15ug/ml) is 
similar to that of wild type, although the starting values were elevated in lag phase (Figure 5). 
Just as in wild type, there were no increases in persistent cells in lag and early log phases 
even though the population size increased. Unchanging persistent cell numbers in this 
growth phase are attributed to nongrowing cells carried over from stationary phase. 
However, when compared to wild type, hipA7 has about 100-fold more persistent cells that 
are carried over from stationary phase, suggesting that the mutants form persistent cells in 
stationary phase at a higher rate. Once mid-log growth is reached, new persistent cells begin 
to form in both wild type and mutant populations, although hipA7 form new persisters at a 
slower rate. Finally, once stationary phase is reached, as in wild-type, all hipA7 cells are now 
persistent to killing by ampicillin, and about 1 % are persistent to killing by ofloxacin. 
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Figure 5 Growth-stage dependence of persistence in E. coli hip A 7 mutants. A cell culture was grown at 37° C, 
for 10 hours, and at various times samples were pulled and exposed to ampicillin, and ofloxacin. Samples were 
exposed to antibiotics for 3 hours and then plated on LB plates and grown overnight to assay persister numbers. 
(39) 
The hip operon 
The hip operon is located at minute 33.8 on the E.coli chromosome (63) in an area 
near the terminus of replication directly opposite oriC (37). Within 100-bp of the hip operon 
are the dif and terC loci, both of which are involved in chromosome partitioning and 
termination of chromosome replication ( 10, 36). As mentioned above, the two genes located 
in the hip operon make up a toxin-antitoxin protein system. hipA codes for a toxin with a 
molecular mass of 49,489 Da, and hipB codes for an antitoxin with a molecular mass of 
10,005 Da (9, 53). Without the nullifying effect of HipB, HipA is extremely toxic to the cell, 
even at very low doses (53). 
The hip operon is not essential for growth, consistent with its variable presence 
among bacterial species (8). One particular study found that out of 40 world wide clinical 
isolates of E. coli, 20% did not contain either of the two hip genes (25). More recently, we 
conducted a BLAST search using hipA and came up with 160 hits containing 90 unique 
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species of bacteria (data not shown). Notably, however, Salmonella species do not contain a 
hipA homologue. 
As mentioned, the hipA 7 allele is the result of two point mutations that cause two 
amino acid substitutions, G22S and D291A (42). To further characterize hipA7, Karch et al. 
analyzed each mutation separately. They found that G22S causes the normally toxic HipA 
protein to become nontoxic, but does not give high persistence. D291A maintains its toxicity 
and confers high persistence. When both mutations are present, hipA7 gives E. coli the 
pleotrophic phenotypes of increased persistence and a cold temperature sensitive block in cell 
division, without being toxic to the cell. At 37°C, hipA7 strains with deletions of the hip 
operon expressing hipA7 from a recombinant plasmid do not result in elevated killing, loss of 
growth rate, or filimentation ( 42). hipA7 is recessive to hipA +, as revealed by the fact that 
high persistence is lost in mutants with hipA + provided in trans (53) . 
hipB is not required for high persistence. As mentioned above, hip operon deletion 
mutants with copies of hipA7 provided on plasmids exhibit elevated levels of persistence 
with or without hipB present (42). It is believed that the mutations associated with hipA7 
also cause a loss of the HipB binding site (9). 
hip operon deletions 
In all phases of growth except stationary and biofilm growth, a deletion of the hip 
operon conveys no measurable phenotype, including no change in levels of persistence when 
compared to wild type strains. The effect of hip operon deletions in stationary phase cells 
will be discussed below. Likewise, strains containing deletions of hipA also have no change 
in phenotype in all phases except stationary (25, 42). Strains containing deletions in the hipB 
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gene, with hipA under the control of a wild type promoter, cannot be created because without 
hipB, levels of the toxin HipA become high enough to kill the cell (63). However, hipA has 
been cloned under tight regulation of the araBAD promoter (42) in strains that have hipB 
deleted. Even when hipA is under PBAD regulation in the presence of glucose, sufficient 
HipA is still produced to cause a significant number of cells to grow slowly or stop growth 
all together (42). This indicates that very few molecules of HipA are required for toxicity. 
Studies testing the results of increasing amounts of HipA have shown that higher than natural 
levels act to slow growth until a plateau is reached where growth stops altogether (25, 42). 
The mechanism of this reduction in growth is not known. 
As mentioned, deletion of the hip operon shows no phenotypic difference during any 
growth phase except stationary and biofilm growth ( 40). About 1 % of E. coli in stationary 
phase are in a persistent state when exposed to ofloxacin, however, the loss of hip causes this 
value to fall 10-fold (44). Biofilm populations with deletions of the hip operon that were 
exposed to ciprofloxacin and mitomycin C saw natural persistence levels diminish 4-fold and 
150-fold respectively. 
The gene order of the hip operon begins with hipB (264 bp), followed by hipA (1,340 
bp). The stop codon of hipB overlaps with the start codon of hipA. Based on its composition 
and location, the promoter region of the hip operon suggests that hipAB is weakly expressed 
(8). Four inverted repeat regions were discovered in the 5' noncoding region. Sequence 
analysis of this region found that one inverted repeat, 0 1, has the sequence TACCN6GGATA 
(where N represents any nucleotide), and the three other inverted repeats further downstream, 
02, 03, 04, having the sequence TATCCNsGGATA. These four operators play a part in 
transcriptional regulation and will be discussed below. In addition to operators, a potential 
integration host factor binding site found in the 5' noncoding region. 
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DNA sequence analysis of hipB revealed that the product has a predicted helix-tum-
helix motif typical of DNA binding proteins (8). Analysis also found that hip encodes a 
transcript composed of rare and infrequently used codons (38, 41) as compared to an average 
E.coli gene typical of poorly expressed genes (8). 
hipA and hipB have been found to autogenously regulate their own transcription. 
This was first observed by the Moyed et al. (8), who created hip promoter-Lacz fusions 
containing the hip promoter region ( -291 to +61 ). When expressed in E. coli it was found 
that transcription of lacZ was 16-fold higher in hipAB deletion mutants. By introducing a 
copy of hipB it was found that transcription of lacZ diminished, suggesting that HipB can 
repress its own transcription. However, HipB alone cannot repress transcription back to wild 
type levels, suggesting a role of HipA in transcription regulation as well. 
HipA and HipB proteins 
Isolation and characterization of the Hip proteins was also done by the Moyed lab (8). 
Besides having the predicted molecular weight and amino acid sequences, HipB was found to 
form dimers with itself, and also with HipA. This is consistent with other proteins containing 
a helix-tum-helix motif. Also, HipA extracts from cells were found exclusively in tight 
dimers with HipB, an expected result of a toxin-antitoxin complex. The affinity of HipA for 
HipB was so high that denaturing conditions were required for their separation. Completely 
pure extracts of HipA were never able to be obtained without at least some trace HipB 
present. Since HipA could not be completely purified, testing of this protein in complete 
isolation from HipB was not done. 
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As stated earlier, HipA and HipB autoregulate their own transcription. Gel 
retardation assays using purified Hip proteins and DNA from the regulatory region showed 
that both HipA and HipB bind specifically to the gene regulatory region. HipB-HipB 
complexes and HipA-HipB complexes both were found to bind to this area. It is not known 
if HipA can bind to this region in the absence of HipB since HipA cannot be purified to 
homogeneity. In later experiments, the Moyed et al. used DNase and methylation assays to 
show that HipA-HipB and HipB-HipB complexes protected all four operators listed above 
from DNase I digestion (8). The protected regions also included the -10 and -35 promoter 
and the transcription start site. Both HipA-HipB and HipB-HipB dimers protected very 
similar locations. These results suggest that transcriptional regulation results from physical 
blockage of RNA polymerase. 
Measurements of natural E. coli Hip protein levels found that for every one HipA 
present there were five molecules of HipB. This is common of toxin-antitoxin systems that 
usually are set up to provide many copies of a short-lived antitoxin along with few copies of 
a more stable toxin molecule (27) 
hipA7 production of persistent cells 
It has been noted that hipA 7 mutant cultures inoculated into fresh media have a 
characteristic extended lag phase as compared to wild type strains (3). A newly inoculated 
culture has two subpopulations, one that has a lag time of around 40 minutes, and another 
that has a lag time averaging 14 hours. It is this subpopulation with extended lag phase that 
makes a hipA7 population highly persistent to antimicrobial challenges. Recent research 
using microfluidic devices to directly observe cells has shown that hipA7 persistent cells in 
lag and early log phase of growth are in fact a result of a preexisting population of 
nongrowing cells that are generated in stationary phase (3). Even before antibiotics were 
applied, direct observation could discern persistent cells by their lack of growth. Because 
hipA7 allows a greater proportion of persistent cells to be generated in stationary phase, 
along with the fact that the only known phenotype of a hipAB operon deletion is a loss of 
persistence in stationary phase, it is reasonable to speculate that the action of hipA occurs 
predominately in stationary phase. 
Cellular action of hipAB and the mutant hipA7 
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It is not known what other cis-acting sequences or gene products interact with HipA 
and HipB. It has recently been discovered that increased cellular doses of HipA are not 
bacteriocidal, but rather bacteriostatic (43). Increased levels of HipA were found to slow 
both RNA and protein synthesis in addition to stopping cellular growth. It was also found 
that the majority of a population exposed to increased levels of hipA for over 6 hours enter a 
viable but nonculturable state. Cells in this state are termed to be living by the results of 
membrane potential tests, but are unable to from colonies. Interestingly, it was found that 
levels of HipA just below the point where growth defects are observed, also convey the 
increased persistence levels (25). In contrast, elevated levels of hipA7 have only very minor 
effects on growth and protein synthesis (43), while still governing high persistence. This 
could indicate multiple functions of natural hipA, some of which are lost by hipA7. 
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One hypothesis for the action of hipA7 was proposed by Korch et al. (42), who 
proposed that like hipA, hipA7 can cause cells to go into dormancy, but the threshold level 
needed to attain dormancy is only reached in small portion of hipA7 mutants. In addition, 
they suggest that perhaps the mode of HipA 7 action is through manipulating cellular 
(p)ppGpp levels (42). Action of hipA7 has been shown to be related to the stringent response 
genes relA and spoT ( 42), which both have the ability to synthesize (p )ppGpp. Experiments 
were done to analyze persistence of hipA7 mutants with deletions in relA, or relA and spoT 
(42). It was shown that loss of relA causes hipA7 mutants to lose a slight degree in 
persistence, and loss of both relA and spoT cause persistence to fall dramatically to levels 
slightly below that of wild type ( 42). Since cells can not synthesize (p )ppGpp without relA 
and spot, it showed that hipA 7 high persistence is linked to the presence of (p )ppGpp. 
hipQ 
Besides hipA, hipQ has been the only other high persistence allele studied. hipQ was 
discovered by Wolfson et al. in 1989 (79). hipQ was found in an attempt to further their 
studies of the mechanisms of quinolone killing by isolating a mutant of E. coli that had 
elevated tolerance to quinolones. However, in addition to having increased tolerance to 
quinolone antibiotics, they found that hipQ mutants also had increased survival to a variety 
of others antibiotics (78, 79). 
hipQ, like hipA, was found to show high persistence to ~-lactam antibiotics, as well as 
quinolone. To date, E. coli hipQ mutants have been found to have increased numbers of 
persistent cells when challenged by a variety of antibiotics that target different cellular 
process (78, 79), with the exception of gentamicin and rifampicin, however. It was also 
found that hipQ mutants are hypersensitive to the mutagen methyl methanesulfonate, 
implying a defect in DNA repair (79). 
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When comparing hipQ and hipA populations to killing by ampicillin in mid-log 
phase, it was observed that the both have very similar fractions of persistent cells (Figure 6). 
The killing of hipQ and hipA7 populations to antibiotics can be broken down into two phases. 
The first phase is an initial short, rapid, killing phase identical to the response of wild-type 
cells, and the second phase is a slow gradual decline in cell viability (Figure 1 ). 
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Figure 6 Time kill studies of wild-type strain KL16 (triangles) and hipQ DSL Strains were exposed to high 
concentrations of norfloxacin (A) and ampicillin (B). (78) 
The location of the hipQ mutant is somewhere around the minute 2 vicinity of the E. 
coli chromosome (78). Although, the minute area is known, the mutation is still yet to be 
identified. There is also evidence that the high persistence phenotype may be the result of 
multiple mutations. For example, although conjugation between a mutant hipQ into wild 
type strains were successful in transferring high persistence to the recipient the high 
persistence phenotype has never been successfully transferred using bacteriophage Pl (78). 
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Wolfson et al. explains the failure of hipQ' s transfer by transduction by the possibility of 
multiple mutations in location close, but far enough away that all can not all be transferred by 
Pl. 
As explained above, hipA 7 high persistence comes from increased number of 
persister cells carried over from stationary phase. As in hipA 7 mutants, hipQ populations 
have an inherent heterogeneity in population growth rate that can be distinguished before an 
antibiotic is even added (3). Unlike hipA7 populations, hipQ mutant populations attain their 
high persistence by their ability to randomly and sporadically switch a fraction of cells to a 
mode of slowed growth. It has been observed that once a cell in a hipQ population randomly 
switches to a slower growth rate, it is inherited for several cell division cycles (3). The 
percent of persistent cells in a hipQ population seem to be dependant on the total number of 
cells in the population; stationary inoculum size is irrelevant. Because hipQ persistence is 
density dependant, their persistence might be governed by quorum sensing. 
Recent theoretical calculations have found that hipQ populations are actually more 
"fit" than wild type cells in environments that are commonly exposed to antibiotics (12). 
Although, wild type levels of persistence proved to be the most fit in most other 
environments that are not exposed to antibiotics often. These two conclusions suggest that 
the fraction of a population that attains a level of persistence has been optimized by 
evolution. However, because of the routine use of antibiotics since their discovery in the 
1940' s, it might be interesting to explore if clinical isolates of bacteria have increased levels 
of persistence. 
Although, hipQ and hipA are both mutations that give high persistence to a wide 
range of antibiotics, there are other differences between the two. Unlike hipA7 mutants, 
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hipQ mutants do not have increased persistence to the protein biosynthesis inhibitor 
gentamicin, or the RNA polymerase inhibitor rifampicin. Also, while hipA persisters appear 
to be created in stationary phase, hipQ mutants are apparently density dependant. hipQ 
mutants also do not have the cold sensitivity associated with hipA7. Identification of the 
mutation(s) causing hipQ would be very valuable in advancing the knowledge of persistence. 
An new attempt to overcome the difficulty of studying the low number of persistent 
cells in a wild type population of E. coli was done recently by Shah et al. (64). They 
developed an assay that collected nongrowing cells from a growing population using a flow 
cytometer. Nongrowing cells were singled out by their lack of GFP fluorescence which was 
under the control of a 16S rRNA promoter that is active only in growing cells. Because 
persistent cells are known to be in a nongrowing state, around 31 % of all nongrowing cells 
that were collected were found to be persistent to ofloxacin exposure. Gene expression 
profiles of the collected nongrowing cells were found to be distinctly different from that of 
stationary or exponential phase of growth, putting persistent cells in a distinct state of 
bacterial physiology. 
Why study persistence? 
In humans, although antibiotics can kill 99.99% of a bacterial population, elimination 
of the relatively few persistent cells that remain is not always easily achieved. 
Immunocompromised individuals such as the elderly, or patients with AIDS, can have a 
difficult time eliminating even a few bacteria. Furthermore, if persistent cells are located in 
biofilms, even healthy individuals can have a difficult time eliminating all bacteria. The 
inability to completely eliminate a bacterial population can lead to the recurrence of 
infections, and increase the chance of generating antibiotic resistant microorganisms (55). 
Understanding persistence should allow us to identify new targets to more effectively 
eliminate bacteria or to increase the efficiency of antibiotics. 
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Microbial biofilms are adherent microbial colonies that are attached to a surface and 
bound together by an outer matrix usually composed of exopolysaccaride (65). Biofilms can 
subsequently form a complex community composed of multiple microbial species (67). This 
slippery conglomeration of bacterial cells allows bacteria to survive and proliferate in hostile 
environments. Biofilms account for nearing 60% of all infections in the U.S. (26), and are 
responsible for the majority of recurrent infections (1, 46). Biofilm infections include those 
of catheters, orthopedic devices, heart valves, venous catheters, artificial joints, as well as 
cystic fibrosis and urinary tract infections. It has been found that bacteria in biofilms are 10-
1000 times less susceptible to antimicrobials (44). While in a protected state, the biofilm 
readily discharges unbound cells that are then free to disperse to new areas. Almost all 
bacterial species have the ability to form biofilms. One explanation for the phenotypic 
tolerance of biofilms includes different nutrient and oxygen gradients throughout the 
biofilms. These variable conditions cause residents of a biofilm to elicit variations of 
phenotypes based on a cells location within the community, including some that are 
insusceptible to antibiotic treatment (29, 77). Mathematical models of biofilms predict that 
bacteria on the outer edges of a biofilm are the most sensitive to antimicrobial treatment (18, 
60), while the majority of the cells in the interior are highly tolerant to antibiotics. 
Researchers have recently attributed the high survivability of biofilms to the same 
mechanisms used by persistent cells (26, 34, 46). This is evident by the observation that 
persistent cells recovered from a biofilm grown planktonically have no change in MIC or 
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MBC. Although, biofilms have no increase in antibiotic resistance, they have the ability to 
survive lethal antimicrobial concentrations, exemplifying conflicting results of real world 
clinical antimicrobial failure despite observing antimicrobial sensitivity in a laboratory. The 
link between biofilms and persistence is the main source of renewed interest in persistent 
cells since its initial discovery. 
Salmonella 
Food-borne diseases are an ever-present challenge to the health and economy of the 
world. Over 200 different diseases are known to be transmitted by food (13). In the United 
States, food-borne pathogens have been reported to cause around 76 million cases of illness, 
323,000 hospitalizations, and 5000 deaths each year (51, 69). An estimated 4.8 to 23 billion 
dollars are lost to food born illness annually in the US (71). Understandably, the 
mechanisms of persistence could potentially help in improved methods of food sanitation by 
developing more effective antimicrobials and disinfectants. 
Salmonella has been recognized as a major cause of intestinal disease in humans for 
many years, but despite this knowledge it still continues to be one of the most common food-
born illnesses on the planet. Annually it has been estimated that over 1.3 billion cases of 
acute gastroenteritis were due to non-typhoidal Salmonella worldwide (57). Currently in the 
US, 30,000-40,000 cases of non-typhoidal salmonellosis are reported to the CDC annually, 
along with approximately 500 fatalities (51). Because most cases of Salmonella infection do 
not cause severe disease, it is thought that only one out of every thirty-eight cases are 
actually reported (16). This brings the actual number of salmonellosis cases in the U.S. to 
around 1.4 million every year. 
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Salmonella are gram negative, motile, non-spore forming, rods, capable of aerobic 
and anaerobic respiration. Infection by Salmonella is almost always due to consumption of 
contaminated food or water, but it can also be transmitted zoonotically (15, 51, 59, 61, 76). 
There are approximately 2500 distinct serovars of Salmonella (35). The genus Salmonella is 
a member of the family Enterobacteriaceae, and is divided into two species: Salmonella 
enterica and Salmonella bongor. Salmonella enterica is further subdivided into six 
subspecies (35), one of which - entericae - contains 99% of all Salmonella serotypes that 
cause human infection (73). Included in subspecies enterica are serovars that cause systemic 
disease, such as Typhi, and serovars that cause gastroenteritis, such as Typhimurium. Some 
servovars of Salmonella are host specific, but most, including Typhimurium, can infect a 
wide range of hosts. The most common zoonotic reservoirs of Salmonella are livestock, 
especially poultry. Although most Salmonella can infect a wide range of hosts, the response 
in each host can be entirely different. For instance, in mice serovar Typhimurium does not 
cause gastroenteritis as it does in humans, rather it causes a fatal systemic infection that is 
very similar to a human Salmonella serovar Typhi infection (72). 
Despite its potential significance, persistence has not been studied in Salmonella. 
Besides being a deadly human pathogen, Salmonella also lacks the hip operon, increasing the 
likelihood that its study will yield new information about persistence. For example, the 
isolation and characterization of new hip mutants of Salmonella would reveal new 
infom1ation about the genetic basis of persistence. The availability of genetic tools and of 
the complete genomic DNA sequence of the S. typhimurium strain LT2 makes this an 
appealing model for further study of persistence. Persistence research using L T2 will not 
only aid research into this poorly understood survival mechanism, but in addition may also 
give knowledge of this important human pathogen. 
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A small fraction of bacterial populations consist of "persistent" cells that are 
phenotypically distinct from the majority of cells by their ability to avoid killing by a variety 
of antimicrobial challenges. Persistence is distinct from resistance in that persistent cells are 
unable to grow in the presence of the antimicrobial agent or treatment, but resume growth 
after the selection has been removed. Presently, little is known about the genetic or 
physiological basis of persistence. In this study we demonstrate that Salmonella enterica 
serovar Typhimurium (S. typhimurium) displays the persistence phenotype. To better 
understand persistence in this important food-borne pathogen, we have isolated 6 mutants 
that show an increased ability to survive exposure to a variety of antibiotics without an 
increase in MIC values. All of the mutants isolated were found to have an extended lag 
phase, but had wild type growth rates in exponential phase. Characterization of the mutants 
indicates that multiple loci appear to contribute to persistence. Mapping the genes for the 
high persistence phenotype will reveal new insights into this widely observed phenomenon. 
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Introduction 
The phenomenon of microbial persistence was first discovered in the 1940' s by 
Bigger when he observed that penicillin was ineffective at sterilizing growing cultures of 
bacteria (6). The subpopulation of cells that survived antibiotic exposure was termed 
"persistent." Persistent bacteria are defined as a phenotypically distinct subpopulation of 
cells in a temporary dormant state that can survive a variety of antimicrobial challenges. 
Persistence is clearly distinct from resistance in that persistent cells are unable to grow in the 
presence of the antimicrobial agent or treatment, and have the same minimal inhibitory 
concentrations (MIC) as non-persistent cells. When an antimicrobial challenge is removed 
persistent cells are able to resume growth, but remain as sensitive to the antimicrobial agent 
to which they were exposed (6, 39). Persistent cells are formed when cells enter a slow or 
nongrowing state and is independent of exposure to antimicrobial agents (3). 
Since its discovery much remains unknown about the genetic and physiological basis 
of persistence. Recently, a renewed interest in persistence has occurred in the quest to 
understand the potential role that persistent cells play in the ability of biofilms to survive 
antimicrobial treatment (26, 46). It is estimated that biofilms cause around 60% of all human 
infections (26) and are responsible for the majority of recurrent infections ( 46, 58). 
Therefore, understanding mechanisms of antimicrobial persistence could have dramatic 
implications for human and animal health. 
To date the study of persistence has been limited largely to high persistence (hip) 
mutants isolated in E.coli (52, 79). Mutations in hipAB and hipQ were originally found by 
screening for mutants with increased ability to survive exposure to ampicillin (hipA) and 
ofloxacin (hipQ) (52, 79), but were later found to have increased persistence to many other 
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antimicrobial challenges. Of the two, only the hipAB locus has been mapped and most of our 
understanding of high persistence has involved studies of the hipA7 allele. 
The hipA7 allele is a recessive, cold sensitive, gain of function mutation that causes 
an increase in the proportion of persistent cells in E. coli (8, 9, 25, 39, 40, 42, 44, 52, 53, 63, 
66). It has been found to increase persistence to many antimicrobial challenges including 
antibiotics that inhibit cell wall, DNA, and protein synthesis, along with exposure to metal 
oxyanions (33, 39, 40, 42, 52, 63). The high persistence phenotype of hipA7 mutants relies 
on the presence of (p )ppGpp ( 42), and causes an inherent heterogeneity of cellular growth 
rates in a growing population (3). Two mutations in hipA are required for the high 
persistence phenotype associated with hipA7 (42). Although the target is not known, hipA 
apparently encodes the "toxin" component of the toxin-antitoxin (TA) module hipAB. The 
facts that hipA is not essential for cell viability and the hipAB operon is not universally 
conserved throughout all bacterial species (42), clouds its normal role in the cell. 
Furthermore, since a deletion of hipAB does not cause a complete loss of persistence (8, 44 ), 
it is clear that it is not the sole contributor to bacterial persistence. One explanation 
suggested by Lewis et al. is that persistence is governed by multiple redundant TA systems 
(40, 44, 64). In this case, eliminating one TA module, such as hipAB, would not eliminate 
wild type persistence because other TA modules, which are found naturally encoded by most 
bacterial chromosomes, compensate for the loss. The discovery of new genes that affect 
persistence should contribute greatly in identifying the mechanisms that persistent cells use 
to alter their physiology. While finding a gene that is universally conserved and eliminates 
persistence completely when inactivated would be highly informative, it is not likely that 
such a gene exists. However, finding additional genes that convey high persistence will give 
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further insight into the potential role of TA modules, or identify additional cellular processes 
involved in persistence. 
In this study, Salmonella enterica serotype Typhimurium (S. typhimurium) was 
chosen because it causes one of the most common food-born illnesses throughout the world. 
Currently in the United States, 30,000-40,000 cases of non-typhoidal salmonellosis are 
reported to the CDC annually, along with approximately 500 fatalities (51). Importantly, S. 
typhimurium does not contain the hip operon, increasing the likelihood that any high 
persistence mutations found in S. typhimurium will yield new information about the process. 
The S. typhimurium strain LT2 was chosen because it is the principle Salmonella strain used 
by researchers, and its entire genome has been sequenced (50). Understanding persistence in 
LT2 will not only give knowledge of survival strategies of this important food-borne 
pathogen, but also lead to new insights into this poorly understood phenomenon. 
Materials and Methods 
Bacterial strains. The strains used in this study are listed in Table 1. 
Primers used. The primers used in this study are listed in Table 2. 
Media and chemicals used 
LB media (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCL), minimal media (lx 
M9 salts,1 mM MgSO4, 5 xl0-4% Bl, 0.2% glucose), and Bochner-Maloy (5 g/L tryptone, 5 
g/L yeast extract, 50 mg/L chlortetracycline, 15 g agar, 10g/L NaCl, NaH2PO4, 12 mg/L 
fusaric acid, 0.014 g/L ZnCh) were made as described by Maloy et al. (49). Mueller-Hinton 
II medium was obtained from Becton Dickinson and Co. (Franklin Lakes, NJ). Antibiotic 
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strips used for measuring minimal inhibitory concentration (MIC) were obtained from AB 
Biodisk (Solna, Sweden). Ampicillin (100 mg/ml), ofloxacin (5 mg/ml in lM NaOH), 
kanamycin (30 mg/ml), chloramphenicol (20 mg/ml in ethanol), piperacillin (100 mg/ml), 
and rifampicin (50 mg/ml in methanol) were obtained from Sigma Chemical Co. (St. Louis, 
MO) and stored at -20°C until use. Fusaric acid (12 mg/ml dissolved in dimethylformamide) 
was obtained from Sigma and prepared prior to each use. Penicillinase was obtained from 
Sigma and was prepared by methods described by Korch et al. ( 42). Penicillinase was 
resuspended at 2500 U/ml in sterile 50 mM Tris-Cl (pH 7.5 at 25°C), 50 mM NaCl, 1 mM 
EDTA, 1 mM dithiothreitol (DTT) and 20% glycerol and frozen at -20°C in 100 µl aliquots. 
Before each use, 100 µl stock solutions were resuspended in 4.9 ml of LB, and transferred to 
a martini mister. Each penicillinase application used 150 µ1. 
Mutagenesis 
The alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) was used since 
this class of mutagen was used successfully to generate high persistence mutants in E. coli 
(52, 78). Exponentially growing cultures of LT2 at a density of 108 CFU/ml were exposed to 
50 µg/ml of MNNG for 10 minutes. After exposure, cells were washed twice and 
resuspended in saline (8.5% NaCl) at a concentration of 109 CFU/ml and incubated 
overnight. Portions of the mutated as well as unmutated control cultures were plated on LB 
+ rifampicin plates to determine the efficiency of the mutagenesis by measuring rifampicin 
resistance. 
Screen for high persistence mutants 
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To screen for high persistence mutants 40 µl of cells were removed from mutagenized 
cell cultures following overnight incubation in saline, and transferred to 40 ml of LB medium 
in a 250 ml baffled flask. The flask was then placed on a shaker at 37°C for 1 hour. 
Ampicillin (100 µg/ml) was added and incubation continued with shaking for 3 hours at 
37°C. The contents of the flask were then centrifuged (8000 rpm) and the pellet was 
resuspended in 40 ml of LB in a sterile 250 ml flask, and incubated with shaking at 37°C for 
1 hour. Ampicillin (100 µg/ml) was added, and the flask again was incubated for 3 hours at 
37°C. After 3 hours the contents of the flask were collected by centrifugation and plated on 
ampicillin LB plates and incubated at 37°C for 24 hours. The plates were then sprayed with 
penicillinase and incubated again at 37°C for an additional 24 hours. Colonies that appeared 
were then scored individually for increased persistence to ampicillin by using sterile 
toothpicks to transfer single colonies to 96 well microtiter plates containing 200 µl of LB per 
well. The plates were incubated overnight at 37°C and each well was then diluted 10-3 
followed by the transfer of 10 µl aliquots to ampicillin (100 µg/ml) plates. Ampicillin plates 
were incubated overnight at 37°C, sprayed with penicillinase, and incubated again at 37°C. 
Spots that showed confluent growth were scored as having high persistent to ampicillin 
(Figure 1 ). Cells from the spots that showed confluent growth were restreaked for single 
colonies. Mutants that formed colonies of comparable size to wild type LT2 were then 
assayed for growth rate and increased persistence to other antibiotics. 
Assay for antibiotic persistence 
To assay the level of persistence, 20 µl of a 5 ml overnight culture was transferred to 
20 ml of LB in a 125 ml baffled flask. After one hour, 500 µl was transferred from the flasks 
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to test tubes containing 500 µl of LB media with ampicillin (100 µg/ml), ofloxacin (5 µg/ml), 
chloramphenicol (200 µg/ml), kanamycin (50 µg/ml), or piperacillin (200 µg/ml) at 2x 
antibiotic concentrations. At the same time the flask contents were diluted and plated on LB 
and LB + arnpicillin plates. The contents of the tubes were incubated for 4.5 hours at 37°C. 
The contents of the tubes were then diluted and plated on LB plates. Cultures containing 
ofloxacin and kanamycin were collected by centrifugation and resuspended in fresh LB 
before diluting to minimize transfer of antibiotics. All plates were incubated overnight at 
37°C. Ampicillin plates were sprayed with penicillinase after the first incubation and 
incubated again for 24 hours. All plates were incubated at room temperature for an 
additional 5 days to allow cells with delayed growth to form colonies. At least 5 antibiotic 
tests were done on each strain using multiple plates. 
Persistence to elevated temperature was tested by exposing overnight cultures to 50°C 
for various times. 200 µl of each overnight culture transferred to a 1.5 ml microcentrifuge 
tube and placed in a 50°C heat block. At various times the samples were removed, diluted, 
and 10 µl spots were transferred to LB plates. LB plates were grown for 24 hours and 
colonies were counted. 
Growth rates of high persistent mutants 
20 µl of overnight cultures were transferred to 20 ml of LB contained in a 125 ml 
baffled flask and incubated at 37°C with shaking. Every 30 minutes an OD reading (600 nm) 
was taken using a Bio-Rad smartspec 3000. 
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Effect of growth phase on persistence 
20 µl of an overnight culture was added to 20 ml of LB contained in a 125 ml baffled 
flask. At various times the following three steps were performed. First, 20 µl samples were 
removed from the cultures, diluted, and 10 µl aliquots were transferred to LB plates to assay 
CFU/ml. Second, 20 µl were removed from the culture, diluted, and 10 µl aliquots were 
transferred to ampicillin plates (100 µg/ml). Third, 500 µl samples were removed from the 
culture and added to test tubes containing ampicillin (200 µg/ml) or ofloxacin (10 µg/ml). 
Test tube cultures were incubated at 37°C with rotation for 4.5 hours, diluted, and 10 µl 
aliquots were transferred to LB plates. Ofloxacin exposed cultures were washed once with 
LB before dilution and plating to minimize antibiotic transfer. All plates were incubated for 
24 hours after aliquot transfer. Ampicillin plates were sprayed with penicillinase after the 
initial incubation and again incubated for 24 hours at 37°C. All plates were allowed to 
incubate for an additional 5 days at room temperature before colonies were counted. Each 
mutant was assayed at least three times. 
Assaying delayed growth 
To measure the proportion of populations that display a delay in the onset of growth, 
a protocol from Balaban et al. (3) was used. 5 ml cultures were grown for 24 hours in LB. 
After overnight incubation, cultures were diluted and 100 µl was spread on LB plates. Plates 
were incubated at 37°C and at various times visible colonies were counted up to 80 hours 
after plating. The number of colonies that appeared after 80 hours of incubation was given 
the value of 100%, and the number of colonies present at all other times was recorded as a 
fraction of this number. 
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MIC Determination 
Using sterile cotton swabs, overnight cultures were spread evenly onto 150 x 15 mm 
Mueller-Hinton II plates. Five different antibiotic stripes were then transferred to each plate 
(as directed by the manufacturer), and incubated overnight at 37°C. MIC values were 
determined by recording the antibiotic concentration on the strip that intersected with the 
point of visible inhibition of bacterial growth. 
Additional assays 
Mutants were tested for growth on minimal + glucose plates by streaking colonies 
and incubating for 24 hours at 37°C. Growth at 30°C and 42°C was also monitored by 
streaking mutants on LB plates and incubating at the respective temperatures for 24 hours. 
Mapping of high persistence mutations 
To map the chromosomal location of the high persistence mutations, random TnlOd 
insertion pools of each mutant were created using P22 generalized transduction protocols 
obtained from the Salmonella Genetic Stock Center (University of Calgary, Alberta, 
Canada). The protocol is available at (http://www.ucalgary.ca/~kesander/Kit 5B.html#5B.1) 
and are based on methods by Kleckner and Roth (22). High persistence mutants were 
transformed with pNK972, encoding the transposase for TnlO. Bacteriophage P22 lysates of 
TT10423 were then generated, and used to transduce TnlOd into each mutant containing 
pNK972. Tetracycline resistant colonies with random Tnl Od inserts in each mutant were 
pooled and used to create new P22 lysates. The P22 lysates made of each random mutant 
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Tnl Od pool were used to transduce wild type LT2, selecting for tetracycline resistance. LT2 
tetracycline resistant transductants were then assayed for high persistence as described above. 
Once a transductant displaying high persistence was found, Mud-P22 prophages 
were used to estimate the general area of the linked Tnl Od marker using strains and protocols 
obtained from the Salmonella Genetic Stock Center 
(http://www.ucalgary.ca/-kesander/Kit ID.html), which are based on methods described by 
Benson and Goldman (5). Mud-P22 strains transfer known regions of the LT2 chromosome. 
The selection used for mapping the location of the Tnl Od insertion was growth on Bochner-
Maloy plates, which selects against cells that are tetracycline resistant. 
Arbitrary primed PCR was used to map the precise locations of Tnl Od elements 
linked to the high persistence mutations. Two rounds of PCR were done using methods 
described by Das et al. ( 19) using primers listed in Table 2. The first round of arbitrary PCR 
used primers ARB3 and TnlOL, followed by a second round of PCR that used primers ARB4 
and ISl0R. 
Results 
Persistence in S. typhimurium 
Characteristic of other bacterial species, S. typhimurium displays persistence to 
antibiotics. Figure 2 and 3 shows that while the majority of bacterial cells are killed by 
exposure to ampicillin or ofloxacin, a small subpopulation of persistent cells survive. To 
identify genes that contribute to this phenotype, we isolated S. typhimurium mutants with 
elevated levels of persistence. 
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Mutagenesis 
Since high persistent mutants of E. coli were previously isolated using a chemical 
mutagen, we adapted a similar approach to isolate mutants of S. typhimurium. Since high 
persistence of E. coli mutants is dependent on entrance into stationary phase (3, 39), it was 
reasonable to predict that new high persistence mutants of S. typhimurium would likewise 
need to enter a period of nongrowth before assaying for antimicrobial persistence. Therefore, 
following exposure to MNNG, cells were allowed to recover for 18 hours in sterile saline. 
Preventing growth of the mutagenized cells prior to screening for elevated persistence also 
ensured that mutants were not out competed by a growth advantage held by wild type cells. 
After an initial screen, numerous mutants were isolated that displayed high 
persistence to ampicillin. As expected, the majority of these mutants had significant 
decreases in growth rate as determined by both colony size and by growth rate 
measurements. Mutants that failed to show growth rates similar to wild type LT2 during 
exponential growth were not characterized further. The remaining mutants were tested for 
increased persistence to ofloxacin to eliminate mutants displaying high persistence specific to 
ampicillin. In the end, six mutants that displayed increased persistence to both ampicillin and 
ofloxacin (Figure 2) were selected for further study. 
Growth rate measurements 
All six of the isolated mutants were found to have extended lag phase growth when 
compared to wild type LT2, and were divided into distinct classes. AS14, ASl 7 and AS18 
initiated growth approximately 30 minutes after LT2; AS15 and AS16 initiated growth 
approximately one hour after LT2 (Figure 4); and AS13 approximately two hours after LT2 
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(Figure 5). Although all mutants had extended lag phases, all were found to have growth rate 
constants nearly identical to LT2. 
Tests of persistence 
Once isolated, mutant and wild type strains were tested for persistence against 
ampicillin, ofloxacin, chloramphenicol, kanamycin, and piperacillin challenges. Mid-lag 
growth phase was chosen as the assay point because during this time the number of persistent 
cells remains fairly constant. Assaying persistence during this period also decreased the 
chances for error that could result if tests were done during mid-exponential growth phase 
where new persistent cells are rapidly generated (Figure 2). All mutants were found to show 
increased levels of persistence to all of the antibiotics tested (Figure 6). All mutants showed 
1-2 orders of magnitude increased survival when exposed to antibiotics for 4.5 hours (Figure 
2), and an increase of 2-3 orders of magnitude when exposed to ampicillin on agar plates for 
24 hours (Figure 3). Of all the antibiotics tested, ofloxacin was the most effective in killing 
both wild type and mutant populations. 
In addition to challenges with antibiotics, killing by elevated temperatures was 
assayed (data not shown). After 4 hours of exposure to 50°C, there was no significant 
difference between killing of the high persisting mutants and LT2. 
Growth phase effect on persistence 
To assay the effect that growth phase has on persistence, a slightly modified protocol 
of one done by the Keren et al. (39) was used. In addition to comparing the high persistent 
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mutants to wild type S. typhimurium, comparisons could also be made to published results of 
E. coli (39). 
Like E. coli, the number of persistent cells was found to change throughout different 
phases of growth. For the most part, similar to E. coli, the number of ampicillin persistent 
cells remained constant throughout lag and early log phase in all strains tested (Figure 2). 
However, compared to E. coli, it was observed that S. typhimurium had naturally higher 
levels of ampicillin persistence from lag to mid-exponential phases of growth. E. coli has 
previously been found to have a ratio of persisters to non-persisters of 10-5 when exposed to 
ampicillin for 3 hours (39), while S. typhimurium had a ratio of 10-2 - 10-3 (Figure 2) when 
exposed for 4.5 hours. Once mid-exponential phase was reached, LT2 generated new 
ampicillin persistence cells at a rapid rate until nearly the entire population was persistent. 
AS13, AS15, ASl 7, and AS18 all had a similar surge in the production of new ampicillin 
persistent cells. However, this surge appeared for a shorter amount of time since all of our 
mutants started out having higher levels of persistence. AS 14, on the other hand, generated 
new persistent cells at a much slower rate as growth progressed. Interestingly, AS16 seemed 
to maintain almost complete ampicillin persistence throughout all growth phases. 
Just as in ampicillin exposure, the level of ofloxacin persistence stayed relatively 
constant throughout lag and early exponential phases of growth. Although there was a slight 
decline in ofloxacin persistence levels of AS14 and AS15 during mid-exponential growth 
phase. LT2 began to form new ofloxacin persistent cells shortly after initiation of 
exponential growth. Unlike LT2, mutant populations did not begin to create new ofloxacin 
persistent cells until later in exponential growth phase. When compared to the creation of 
new ampicillin persistent cells, the appearance of ofloxacin persistent cells occurred much 
more gradually (Figure 2). 
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Because S. typhimurium has such high levels of persistence when exposed to 
ampicillin for 4.5 hours, 24 hour persistence assays were also done on LB + ampicillin plates 
(Figure 3). Extending ampicillin exposure time brought the proportion of persistent cells in 
LT2 down to 10-5, which is similar to the ratio seen in E.coli. It is interesting that the level 
of LT2 persistence to ampicillin in this assay appeared to be density dependant. LB + 
ampicillin plate persistence levels of AS13, AS14, and AS18 stayed relatively constant up 
until mid-exponential phase, where new persistent cells begin to gradually be generated. 
Figure 3 shows that the level of persistent cells of AS 15 and AS 17 appeared to decline 
slightly in exponential growth phase until stationary phase was reached, at which point new 
persisters were created. 
Delayed growth tests 
During the course of characterizing the high persistent mutants, it became apparent 
that the mutants formed new colonies for several days after transfer onto LB plates, while 
essentially all of the LT2 colonies appeared within 24 hours following plating onto LB plates 
(Figure 7). This observation suggested that a significant proportion of the mutants remained 
dormant even after plating onto nutrient rich LB. Because of this result, the total number of 
persistent cells in all tests was not recorded until 4-5 days after the initial 24 hour incubation 
at 37°C. 
To quantify these observations, the growth assays shown in Figure 8 were performed. 
All of our mutants have a significant portion of their population delaying exit from stationary 
phase. While after 11 hours of incubation, wild type LT2 had essentially 100% colony 
appearance, the high persistent mutants had only 40%-60% of their total colonies appear. 
AS14-AS18 had similar delays in colony formation. We also observed that AS13 had the 
highest percent of mutant colonies found after 11 hours of growth at 37°C but the lowest 
percent after 48 hours. 
Minimal Inhibitory Concentration 
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MIC tests confirmed that none of the high persistence mutants showed increased 
resistance to ampicillin, ofloxacin, kanamycin, chloramphenicol, or piperacillin. Figure 9 
shows a typical result from a MIC test along with the MIC values of each high persistent 
mutant. The MIC value was taken as the concentration listed on the MIC strip that 
intersected with bacterial growth inhibition. AS 13 had a slight increase in resistance to 
ofloxacin, however, this increase was only 2-fold and was not considered significant. 
Furthermore, construction of AS19 and AS20 by transferring the mutation that causes high 
persistence from AS 13 into LT2 using P22 transduction showed that a second mutation was 
apparently responsible for the slight increased ofloxacin resistance and not related to the high 
persistence phenotype. 
Further characterization of mutants 
Growth was also tested at different temperatures to ascertain if any of the high 
persistence mutants showed temperature-sensitive mutations or cold-sensitivity phenotype, as 
reported with E. coli hipA7 mutants (63). None of the mutants tested had any visible 
difference of growth on LB plates at 30°C or 42°C (data not shown). 
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Tests of growth on defined minimal medium plates revealed that AS 13 and AS 17 
were auxotrophs, while AS 15 and AS 16 grew slightly slower than LT2 on minimal plates. 
However, once the mutation causing high persistence in AS 13 was moved into wild type LT2 
by P22 transduction (see next section), auxotrophy was lost, although growth remained slow 
on defined minimal medium. Although AS 19 and AS20 are prototrophs, both maintain the 
extended growth phenotype seen with AS13. 
Mapping of high persistent mutants 
To determine the chromosomal location of the mutations causing high persistence, 
random Tnl Od insertions were used to generate linked genetic markers. Bacteriophage P22 
mediated transduction was then used to transfer the pooled Tnl Od inserts into wild type L T2 
followed by screening for TetR and high persistence. To date four TnlOd markers have been 
found to be linked to three separate mutations causing high persistence (Table 1 ). AS 19 and 
AS20 have a TnlOd linked to the mutation that causes high persistence in AS13, AS23 and 
AS24 a TnlOd linked to the mutation in AS18, and AS25 has a TnlOd linked to the mutation 
in AS15. 
Mud-P22 mapping narrowed down the location of the Tnl Od markers of AS 19 and 
AS20 to between minute 40 and 50 of the LT2 genome. Arbitrary PCR mapping results 
showed that AS19 has a TnlOd insert in yegS and AS20 has a TnJOd insert in stcC, both of 
which are found at min 43. Data from P22 cotransduction experiments using AS19 and 
AS20, showed that the high persistence phenotyped was linked to tetracycline resistance at 
7.25% and 11.18% respectively. This suggests that the high persistence mutation is 
somewhere between base pairs 2203325 and 2225259 of the LT2 chromosome (50). The 
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genes found in this region are listed in Table 3. In this vicinity are various genes, including 
an operon that codes for a multi-drug transporter (yegNOB baeSR) (4, 54) as well genes 
related to heat shock and DNA repair. There are, however, no toxin-antitoxins modules 
found in this region. 
Discussion 
As observed in other bacteria, S. typhimurium displays persistence. Similar to E. coli, 
the levels of persistence in wild type S. typhimurium were found to be around 10-5 when cells 
in mid-exponential phase of growth were exposed to ampicillin for 24 hours. While this 
value is apparently sufficient for bacteria to survive antimicrobial challenges, it is too low to 
perform meaningful physiological studies on persistent cells. To overcome this obstacle we 
have isolated mutants exhibiting enhanced levels of persistent cells. In total, five separate 
mutagenesis experiments were performed on LT2 yielding 6 high persistence mutants 
deemed suitable for further study. Each mutant was found to have increased persistence to 
multiple antibiotics, indicating that they show increased persistence in general and not to any 
one specific challenge (Figure 6). None of the mutants showed any increases in resistance to 
the antibiotics used in our persistence assays. 
All S. typhimurium high persistent mutants isolated had a large subpopulation of cells 
that show delayed growth. However, all mutants had exponential growths rates that were 
similar to that of wild type, indicating that the high persistence found cannot be attributed to 
an overall slowed growth rate. A significant percent of each high persistent mutant 
population did not immediately resume growth even when placed in an ideal growth 
environment (Figure 8). The cells that do immediately initiate growth likely become highly 
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susceptible to antibiotic killing, thus explaining the increased persistence of the mutants. It is 
not known what causes our high persistent mutants to delay growth. The mechanisms the S. 
typhimurium high persistent mutants use to delay growth could possibly be related directly to 
the one used by small subpopulations of wild type persistent cells, or could be a new gain of 
function. This distinction awaits mapping the genes causing high persistence. 
Balaban et al. used microfluid devises to directly observe E. coli high persistent 
mutants. They concluded that hipA7 and hipQ gain high persistence by two different means 
(3). They designated hipA7 high persistent cells as type I, which are persistent cells carried 
over from stationary phase, while hipQ high persistent cells were designated type II, which 
are persistent cells that are randomly generated in actively growing cultures. Although we 
cannot conclude precisely if the high persistence mutants isolated in this study fall into class 
I or II it is most likely that our they are class I mutants. This is due to the observation that 
the ratio of persistent to non-peresistent cells do not immediately start increasing with 
population growth, which would be expected in class II persistence. 
While delayed growth is most likely what grants our mutants increased persistence, it 
also is a hindrance to population proliferation. Because of this, revertants were frequently 
observed that showed a decline in persistence. This is not surprising, because cells that 
revert have a shortened lag phase giving them a growth advantage under non-selective 
conditions. 
AS 19 and AS20 were both constructed by transferring Tnl 0d markers linked to the 
high persistence mutation of AS 13 to wild type L T2. Along with high persistence, both 
AS19 and AS20 have the extended lag growth phase observed in AS13. However, AS19 and 
AS20 lost the auxotrophy and slight ofloxacin resistance associated with AS 13, indicating 
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AS 13 has multiple mutations. Finding multiple mutations is not surprising given the fact that 
the high persistent mutant hipA7, and most likely hipQ in E. coli, result from multiple 
mutations. The locations of TnJ Od in AS 19 and AS20 were both found to be at minute 43 of 
the LT2 genome. P22 cotransduction using AS 19 and AS20 suggest that the high persistence 
mutation is between base pairs 2203325 and 2225259. As noted, no toxin-antitoxin modules 
can be found in this area, suggesting that persistence may also be governed by other means. 
Although, the high persistence mutation of AS13 is close to being identified, 5 other 
mutants remain unmapped. Until the exact nature of the mutations causing high persistence 
in these mutants is known, it is difficult to speculate what is causing their increased 
persistent. As mentioned, toxin-antitoxin modules are known to cause increases in 
persistence ( 40, 44, 64) and could be one potential candidate. A mutation causing the 
overexpression of the toxin component of a toxin-antitoxin module could potentially create 
increases in persistence. It is also known that sublethal expression of unnatural molecules 
that damage the cell (74) can increase persistence. If a mutation caused a normally nontoxic 
molecule to suddenly damage the cell at minor levels, it could cause a portion of cells to stop 
growing and enter a persistent state. Another possible mechanism is by having a mutation 
that modifies a cellular process known to naturally induce dormancy. Stringent response and 
DNA repair response are both cellular processes known to halt cell division. Both processes 
also are known to possess components that when altered can affect persistent cell levels (20, 
42). Genes involved in DNA repair processes (dcd, udk and alkA) are found in the list of 
possible high persistence genes (Table 3). 
Once the high persistence mutations are mapped it will be interesting to see what 
effects increased gene expression or knockouts have on persistence. In addition, expression 
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profiling of the mutants could shed light on regulatory networks important for persistence. It 
would also prove beneficial to test what effect high persistence mutants have on the 
pathogenicity of Salmonella in animal model such as mice. 
Persistence appears to be another means by which bacteria use to survive rapidly 
changing environments. While persistent cells may not have the ability to grow in the 
presence of an antimicrobial challenge, like a resistant mutant, the phenotype can contribute 
to survival under adverse conditions. For example, persistent cells should allow the survival 
of a population to antimicrobials that otherwise might not be easily adapted to by 
spontaneous mutation. Persistence can give a cell more time to overcome a particular 
challenge by becoming resistant either by mutation or by horizontal gene transfer. The 
reemergence of a bacterial population by the survival of persistent cells can occur whenever 
complete sterilization does not occur. Biofilms in human and animal infection and food 
sanitation are two areas where this reemergence can be potentially dangerous. Further 
investigations into understanding the mechanisms of persistence will prove valuable for 
future treatments of infectious bacteria. 
Table and figure titles 
Table 1. Bacterial strains used in this study. 
Table 2. Primers used 
Table 3. Genes in chromosomal region of S. Typhimurium near the high persistence 
mutation of AS19. 
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Figure 1. Screen for high persistence mutants. Cultures were grown overnight in a 96 well 
rnicrotiter plate and exposed to LB + ampicillin plates as described in Material and Methods. 
After overnight incubation at 37°C (A), LB + ampicillin plates were sprayed with 
penicillinase, and incubated for an additional 24 hours (B). 1 and 2, LT2; 3 and 4, AS13; 5, 
AS14; 6, AS15; 7, AS16; 8, AS17; 9, AS18. 
Figure 2. Effect of growth phase on persistence. At various times growing cultures of LT2, 
AS13, AS14, AS15, AS16, AS17, and AS18 were assayed for CFU/ml (squares) or exposed 
to ampicillin (circles) or ofloxacin (triangles). See Materials and Methods for a full 
description. 
Figure 3. Effect of growth phase on LB + ampicillin plate persistence. At various times 
growing cultures of LT2, AS13, AS14, AS15, AS16, AS17, and AS18 were assayed for 
CFU/ml (squares) or exposed to LB+ ampicillin plates for 24 hours (circles). See Materials 
and Methods for a full description. 
Figure 4. Growth curves of high persistent mutants. Growth assays were performed as 
described in Material and Methods. At various times OD (600 nm) values of growing 
cultures were assayed. Squares, LT2; circles, AS14; triangles, AS15; stars, AS16; diamonds 
AS17, asterisks, AS18. 
Figure 5. Growth curves AS13, AS19 and AS20. Growth assays were performed as 
described in Material and Methods. At various times OD at 600 nm was taken. Squares, 
AS13; circles, AS19; triangles, AS20. 
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Figure 6. Survival of LT2 and high persistence mutants following exposure to various 
antibiotics. Assays were performed as described in materials and methods. Cultures were 
exposed to ampicillin (100 µg/ml), ofloxacin (5 µg/ml), kanamycin (50 µg/ml), 
chloramphenicol (200 µg/ml) or piperacillin (200 µg/ml) for 4.5 hours, and to ampicillin 
plates for 24 hours. Order of columns from left to right are Black, CFU/ml before antibiotic 
exposure; white, ampicillin exposed CFU/ml; grey, ofloxacin exposed CFU/ml; diagonal 
lines, kanamycin exposed CFU/ml; light grey, chloramphenicol exposed CFU/ml; crossed 
lines, piperacillin exposed CFU/ml; horizontal lines, ampicillin plate exposed CFU/ml. 
Figure 7. Delayed colony formation of high persistent mutants. Growing cultures of LT2 
(A, B) and AS 13 (C, D) were exposed to ampicillin. 100 µl of LT2 (undiluted) and AS 13 
(diluted 10-2) were transferred to LB plates. Plates were grown for 24 hours at 37 degrees 
(A, C) followed by continued incubation at room temperature for 5 days (B,D). 
Figure 8. Delayed growth of high persistent mutants. Overnight cultures of LT2 (squares); 
AS13 (circles); AS14 (triangles); AS15 (stars); AS16 (diamonds); AS17 (asterisks); and 
AS18 (crosses) were diluted and grown on LB plates as described in Materials and Methods. 
At various times visible colonies were counted up to 80 hours after plating. The fraction of 
cells observed equals the number of colonies present at each time point divided by the total 
number of colonies after 80 hours. 
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Figure 9. Minimum inhibitory concentration determination. Top. A Mueller-Hinton II plate 
spread with wild type LT2 and antibiotic test strips were applied as described in Materials 
and Methods. MIC values were determined as the point where bacterial growth inhibition 
intersected with each strip, as shown by the arrows. A, chloramphenicol; B, ampicillin; C, 
amoxicillin; D, Ofloxacin; E, piperacillin. Bottom. MIC values of LT2 and high persisting 
mutants determined using antibiotic strip method. 
Tables and Figures 
Tablet 
Strain 
LT2 
AS13 
AS14 
AS15 
AS16 
AS17 
AS18 
AS19 
AS20 
AS23 
AS24 
AS25 
Genotype and phenotype 
Wild type Salmonella enterica serotype Typhimurium 
High persistence mutant isolated from mutagenesis 1. 
High persistence mutant isolated from mutagenesis 2. 
High persistence mutant isolated from mutagenesis 3. 
High persistence mutant isolated from mutagenesis 3. 
High persistence mutant isolated from mutagenesis 4. 
High persistence mutant isolated from mutagenesis 4. 
L T2 that has the high persistence mutation from AS 13 linked to Tnl 0d 
L T2 that has the high persistence mutation from AS 13 linked to Tnl 0d 
LT2 that has the high persistence mutation from AS18 linked to Tnl0d 
LT2 that has the high persistence mutation from AS18 linked to Tnl0d 
LT2 that has the high persistence mutation from AS15 linked to Tnl0d 
TT10423 proAB47 IF' pro(+) lac(+) zz/-1831 ::Tnl0L116L117 
TT10427 LT2/pNK972 
DH5a E.coli cloning vector F <D80lacZL1Ml5 Ll(lacZYA-argF)Ul69 recAl endAl hsdRl 7(rk", mk+) phoA supE44 thi-1 gyrA96 re/Al 11,-
* American Type Culture Collection 
**Salmonella Genetics Stock Center 
Source 
ATCC 
700720* 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
This study 
SGSC** 
SGSC** 
Lab 
Collection 
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Table 2 
Primer Seguence Source 
ARBl 5'-GGCCAGGCCTGCAGATGATGNNNNNNNNNNCATAT-3' (47) 
ARB2 5'-GGCCAGGCCTGCAGATGATG-3' (47) 
ARB3 5'-GGCCACGCGTCGACT AGTACNNNNNNNNNNACGCC-3' (47) 
ARB4 5'-GGCCACGCGTCGACTAGTAC-3' (47) 
TNIOL 5'-ACCAACCA TTTGTT AAA TCAGTTTTTGTTGTGA-3' (62) 
IS10R2 5'-CAAGATGTGTATCCACCTT AACTT AATGATTTT-3' (62) 
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Table 3 
Gene 
Locus Symbol Common Name S'End 3'End 
STM2119 yegH putative inner membrane protein 2203325 2204905 
STM2120 asmA suppressor of ompF assembly mutants 2206847 2204991 
STM2121 dcd dUTPase 2207467 2206886 
STM2122 udk uridine/cytidine kinase 2208199 2207558 
STM2123 yegE putative PAS/PAC domain diguanylate cyclase/phosphodiesterase domain 1 2208530 2211520 
STM2124 alkA 3-methyl-adenine DNA glycosylase II 2212357 2211488 
STM2125 yegD putative heat shock protein 2212491 2213843 
STM2126 None putative HlyD family secretion protein 2214284 2215525 
STM2127 yegN para! putative outer membrane receptor 2215525 2218647 
STM2128 yegO putative resistance protein ( efflux transporter), outer membrane 2218648 2221728 
STM2129 yegB putative MFS family transport protein 2221725 2223137 
STM2130 baeS sensory kinase in two-component regulatory system with baeR 2223137 2224540 
STM2131 baeR response regulator in two-component regulatory system with baeS 2224537 2225259 
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Figure 9 
Minimal Inhibitory Concentrations 
Strai Ampicillin Piperacillin Amoxicillin Chloramphenicol Ofloxacin 
n (µg/ml) (µg/ml) (µg/ml) (µg/ml) (µg/ml) 
LT2 1 1.5 - 2 1.5 - 2 3-4 0.125 - 0.19 
AS13 0.75 1.5 - 2 1 4 0.25-0.38 
AS14 0.75 1.5 1 2-3 0.125 - 0.19 
AS15 0.75 2 1.5 3-4 0.125 - 0.19 
AS16 2 1.5 2 0.125 - 0.19 
AS17 1 1.5 - 2 3 3-4 0.125 -0.19 
AS18 1 1.5 - 2 2 4 0.125 - 0.19 
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General Conclusions 
Persistence is a survival mechanism used by most if not all bacteria to bypass the 
lethal effect of antimicrobial challenges. While persistent cells are genotypically identical, 
they represent a phenotypically distinct subpopulation within a bacterial culture. Despite the 
prevalence of persistence, it remains a poorly understood phenomenon, however, recent 
evidence that persistence may be involved in increased antibiotic resistance of biofilms has 
spurred new research into the topic. 
One of the difficulties that has made research on this topic difficult is that persistent 
cells are produced at very low levels relative to the entire bacterial population. The isolation 
of mutants that show increased persistence was first described by Moyed et al. (52), who 
used EMS to isolate the high persistence mutants for Escherichia coli. To date, this hipA 
(high persistence) mutant is the only well characterized high persistence strain available. 
However, hipA is not a highly conserved gene in bacteria. To further explore this 
phenomenon, we used chemical mutagenesis to isolate 6 high persistence mutants of 
Salmonella enterica serotype Typhimurium strain L T2. S. typhimurium was chosen as our 
test organism because it is one of the most important food-borne pathogens on the planet, and 
it does not contain an orthologue of hipA. In total, six mutants were isolated with increased 
persistence to a number of antibiotics while maintaining exponential growth rates without 
increased antibiotic resistance. All six mutants have an extended lag phase of growth that 
appears to contribute to high persistence. Characterization of the mutants suggests there are 
multiple alleles that can yield a high persistence phenotype. 
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In addition to characterizing the mutants, the genes responsible for the phenotype are 
currently being mapped. This is being done by first isolating linked Tnl0d markers and then 
mapping the marker by arbitrary PCR. Once mapped, it will be interesting to see what effect 
further modifications of the high persistence gene, such as over expression and deletion, have 
on persistence levels. It will also be beneficial to test persistence in other areas, for example 
antimicrobials that commonly used in food sanitation or preservation. Testing the high 
persistent mutants in model organisms, such as mice, for pathogenicity should also be 
beneficial. A better understanding of persistence could lead to the develop of new 
supplements to antibiotics that either induce persistent cells into growth, or counter 
molecules that block of the entry of the bacterial cells persistent state. Inducing bacteria into 
growth places bacteria in their most vulnerable state could make antibiotic treatment more 
effective. 
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